Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma

American Journal of Obstetrics and Gynecology

Volumn 209, Issue 2, 2013, Pages 142.e1-142.e6

  Saarelainen, Sami K ^a   Peltonen, Nina ^b   Lehtimäki, Terho ^b,c   Perheentupa, Antti ^d   Vuento, Maarit H ^a   Mäenpää, Johanna U ^a,c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b FIMLAB LABORATORIES   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

CA125; ELISA; endometrial carcinoma; HE4; stage

Indexed keywords

CA 125 ANTIGEN; HUMAN EPIDIDYMIS PROTEIN 4;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; ENDOMETRIUM CARCINOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 84880918015     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.04.014     Document Type: Article

References (30)

1. J.I. Sorosky Endometrial cancer Obstet Gynecol 111 2008 436 447
2. U.N. Ryoo, C.H. Choi, and J.Y. Yoon MR imaging in endometrial carcinoma as a diagnostic tool for the prediction of myometrial invasion and lymph node metastasis Cancer Res Treat 39 2007 165 170
3. A.G. Rockall, R. Meroni, and S.A. Sohaib Evaluation of endometrial carcinoma on magnetic resonance imaging Int J Gynecol Cancer 17 2007 188 196
4. S. Kang, W.D. Kang, and H.H. Chung Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study J Clin Oncol 30 2012 1329 1334
5. J. Nicklin, M. Janda, and V. Gebski The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer Int J Cancer 131 2012 885 890
6. H.S. Kim, C.Y. Park, and J.M. Lee Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi-center study Gynecol Oncol 118 2010 283 288
7. C. Kirchhoff, I. Habben, R. Ivell, and N. Krull A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors Biol Reprod 45 1991 350 357
8. D. Bouchard, D. Morisset, Y. Bourbonnais, and G.M. Tremblay Proteins with whey-acidic-protein motifs and cancer Lancet Oncol 7 2006 167 174
9. K. Iwahori, H. Suzuki, and Y. Kishi Serum HE4 as a diagnostic and prognostic marker for lung cancer Tumour Biol 33 2012 1141 1149
10. R.L. O'Neal, K.T. Nam, and B.J. Lafleur Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas Hum Pathol 44 2013 734 742
11. M. Kamei, S. Yamashita, and K. Tokuishi HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer Anticancer Res 30 2010 4779 4783
12. R.G. Moore, A.K. Brown, and M.C. Miller Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus Gynecol Oncol 110 2008 196 201
13. R.G. Moore, C.M. Miller, A.K. Brown, K. Robison, M. Steinhoff, and G. Lambert-Messerlian Utility of tumor marker HE4 to predict depth of myometrial invasion in endometrioid adenocarcinoma of the uterus Int J Gynecol Cancer 21 2011 1185 1190
14. E. Kalogera, N. Scholler, and C. Powless Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer Gynecol Oncol 124 2012 270 275
15. R.G. Moore, D.S. McMeekin, and A.K. Brown A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass Gynecol Oncol 112 2009 40 46
16. K. Huhtinen, P. Suvitie, and J. Hiissa Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts Br J Cancer 100 2009 1315 1319
17. D.G. Mutch The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas Gynecol Oncol 115 2009 325 328
18. J.M. Cragun, L.J. Havrilesky, and B. Calingaert Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer J Clin Oncol 23 2005 3668 3675
19. J.K. Chan, M.K. Cheung, and W.K. Huh Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients Cancer 107 2006 1823 1830
20. I. Ben-Shachar, J. Pavelka, and D.E. Cohn Surgical staging for patients presenting with grade 1 endometrial carcinoma Obstet Gynecol 105 2005 487 493
21. P. Benedetti Panici, S. Basile, and F. Maneschi Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial J Natl Cancer Inst 100 2008 1707 1716
22. ASTEC study group H. Kitchener, A.M. Swart, Q. Qian, C. Amos, and M.K. Parmar Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 2009 125 136
23. J.K. Chan, D.S. Kapp, and M.K. Cheung Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer Am J Obstet Gynecol 198 2008 216.e1 216.e5
24. D.S. Chi, R.R. Barakat, and M.J. Palayekar The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology Int J Gynecol Cancer 18 2008 269 273
25. E. Bignotti, M. Ragnoli, and L. Zanotti Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients Br J Cancer 104 2011 1418 1425
26. I. Mutz-Dehbalaie, D. Egle, and S. Fessler HE4 is an independent prognostic marker in endometrial cancer patients Gynecol Oncol 126 2012 186 191
27. R. Angioli, F. Plotti, and S. Capriglione The role of novel biomarker HE4 in endometrial cancer: a case control prospective study Tumour Biol 24 2013 571 576
28. R.G. Moore, M.C. Miller, E.E. Eklund, K.H. Lu, R.C. Bast, and G. Lambert-Messerlian Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age Am J Obstet Gynecol 206 2012 349.e1 349.e7
29. N. Bolstad, M. Oijordsbakken, K. Nustad, and J. Bjerner Human epididymis protein 4 reference limits and natural variation in a Nordic reference population Tumour Biol 33 2012 141 148
30. M. Sneve, and R. Jorde Cross-sectional study on the relationship between body mass index and smoking, and longitudinal changes in body mass index in relation to change in smoking status: the Tromso study Scand J Public Health 36 2008 397 407